Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
about
Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertensionTRP channels in hypertension.Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?Endothelin receptor antagonists as antihypertensives: the next frontier.Efficacy and safety of darusentan: a novel endothelin receptor antagonist.A historical perspective on the role of sensory nerves in neurogenic inflammation.
P2860
Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Dual ET(A)/ET(B) vs. selective ...... s with pulmonary hypertension.
@ast
Dual ET(A)/ET(B) vs. selective ...... s with pulmonary hypertension.
@en
type
label
Dual ET(A)/ET(B) vs. selective ...... s with pulmonary hypertension.
@ast
Dual ET(A)/ET(B) vs. selective ...... s with pulmonary hypertension.
@en
prefLabel
Dual ET(A)/ET(B) vs. selective ...... s with pulmonary hypertension.
@ast
Dual ET(A)/ET(B) vs. selective ...... s with pulmonary hypertension.
@en
P2860
P1476
Dual ET(A)/ET(B) vs. selective ...... s with pulmonary hypertension.
@en
P2093
P2860
P356
10.1111/J.1365-2362.2006.01691.X
P478
36 Suppl 3
P577
2006-09-01T00:00:00Z